XML 29 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Segment and Geographic Data
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
We segregate our operations into two reportable business
segments: (i) MedSurg and Neurotechnology and (ii)
Orthopaedics which aligns to our internal reporting structure and
how our Chief Operating Decision Maker (CODM) assesses the
performance of and allocates resources. The CODM is the Chief
Executive Officer. The CODM makes decisions on resource
allocation, assesses performance of the business, and monitors
budget versus actual results using segment operating income.
Our reportable segments and related disclosures reflect certain
reclassifications of prior year amounts from our Orthopaedics
segment to our MedSurg and Neurotechnology segment due to
changes in our internal reporting structure.
Segment Results
Three Months
2025
2024
MedSurg and Neurotechnology
$3,511
$3,097
Orthopaedics
2,355
2,146
Net sales
$5,866
$5,243
MedSurg and Neurotechnology
$1,321
$1,238
Orthopaedics
629
591
Cost of sales
$1,950
$1,829
MedSurg and Neurotechnology
$226
$195
Orthopaedics
140
134
Segment research, development and
engineering expenses
$366
$329
MedSurg and Neurotechnology
$937
$763
Orthopaedics
847
751
Segment selling, general and
administrative expenses
$1,784
$1,514
MedSurg and Neurotechnology
$57
$54
Orthopaedics
98
108
Segment depreciation and amortization
$155
$162
Corporate and Other
$39
$40
Amortization of intangible assets
167
153
Total depreciation and amortization
$361
$355
MedSurg and Neurotechnology
$970
$847
Orthopaedics
641
562
Segment operating income
$1,611
$1,409
Items not allocated to segments:
Corporate and Other
$(267)
$(263)
Inventory stepped up to fair value
(34)
—
Acquisition and integration-related charges
(185)
13
Amortization of intangible assets
(167)
(153)
Structural optimization and other special
charges
(41)
(11)
Goodwill and other impairments
(35)
(3)
Medical device regulation
(12)
(13)
Recall-related matters
(33)
(5)
Regulatory and legal matters
—
(2)
Consolidated operating income
$837
$972
Segment Assets
March 31
December 31
2025
2024
Assets:
MedSurg and Neurotechnology
$26,912
$23,115
Orthopaedics
17,878
18,507
Total segment assets
$44,790
$41,622
Corporate and Other
1,216
1,349
Total assets
$46,006
$42,971